Glutamate co-release from inhibitory nigral neurons reverses motor deficits in a Parkinson’s disease mouse model

Abstract Degeneration of midbrain dopamine neurons in Parkinson’s disease increases inhibitory output from the basal ganglia, including from GABAergic neurons of the substantia nigra pars reticulata (SNr), thereby suppressing thalamocortical drive and impairing movement. Whether altering the transmitter output of these inhibitory neurons can restore circuit function remains unknown. Here, we genetically reprogrammed mouse SNr GABAergic neurons to co-release glutamate by Cre-dependent expression of the vesicular glutamate transporter VGLUT2. VGLUT2 expression was both necessary and sufficient to induce glutamate co-release and activate postsynaptic glutamate receptors in thalamic target neurons. In a mouse model of unilateral dopamine depletion, ectopic VGLUT2 expression robustly restored motor performance. These findings demonstrate that basal ganglia output neurons retain the capacity for functional transmitter reconfiguration and that inducing glutamate co-release in SNr GABA neurons can reverse pathological motor deficits resulting from dopamine denervation.

Authors

Institutions

Publication Details

Journal
npj Parkinson s Disease
Published
2026-08-03
DOI
https://doi.org/10.1038/s41531-026-01508-3
Primary Topic
Neurological disorders and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glutamate co-release from inhibitory nigral neurons reverses motor deficits in a Parkinson’s disease mouse model

Sophia Khom, Thomas Steinkellner, Sofia Ines Garcia Moreno, Catherine Gilbert et al.
npj Parkinson s Disease
Neurological disorders and treatments
article

Glutamate co-release from inhibitory nigral neurons reverses motor deficits in a Parkinson’s disease mouse model

Sophia Khom, Thomas Steinkellner, Sofia Ines Garcia Moreno, Catherine Gilbert, Laureta Gashi, Marina Lukenic
article en

Abstract

Abstract Degeneration of midbrain dopamine neurons in Parkinson’s disease increases inhibitory output from the basal ganglia, including from GABAergic neurons of the substantia nigra pars reticulata (SNr), thereby suppressing thalamocortical drive and impairing movement. Whether altering the transmitter output of these inhibitory neurons can restore circuit function remains unknown. Here, we genetically reprogrammed mouse SNr GABAergic neurons to co-release glutamate by Cre-dependent expression of the vesicular glutamate transporter VGLUT2. VGLUT2 expression was both necessary and sufficient to induce glutamate co-release and activate postsynaptic glutamate receptors in thalamic target neurons. In a mouse model of unilateral dopamine depletion, ectopic VGLUT2 expression robustly restored motor performance. These findings demonstrate that basal ganglia output neurons retain the capacity for functional transmitter reconfiguration and that inducing glutamate co-release in SNr GABA neurons can reverse pathological motor deficits resulting from dopamine denervation.

npj Parkinson s Disease
University of Vienna (AT), Medical University of Vienna (AT)
Austrian Science Fund
Good health and well-being
Openalex Percentile: Top 9%
Neurological disorders and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.